Innospec Quarterly Balance Sheet
NASDAQ: IOSPIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Innospec financial position
As of Jun 30, 2026, Innospec reported total assets of $1.85 billion, up 2.2% from a year earlier against total liabilities of $495.2 million. Shareholders' equity stood at $1.34 billion, or 72.8% of assets. The company held $250.2 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 2.78, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Innospec balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 250.20M | 289.10M | 292.50M | 270.80M | 266.60M | 299.80M | 289.20M | 303.80M | 240.20M | 270.10M | 203.70M | 207.20M |
| Receivables | 408.60M | 354.20M | 342.30M | 349.50M | 336.10M | 343.50M | 341.70M | 327.60M | 300.30M | 318.20M | 359.80M | 305.20M |
| Inventory | 337.30M | 321.50M | 329.30M | 345.20M | 336.80M | 315.40M | 301.00M | 319.30M | 313.50M | 304.30M | 300.10M | 331.50M |
| Total Current Assets | 1.02B | 999.10M | 1.00B | 988.80M | 969.70M | 977.10M | 956.60M | 965.60M | 876.80M | 912.90M | 885.70M | 863.70M |
| Property, Plant & Equipment | 293.30M | 285.70M | 286.10M | 278.60M | 295.80M | 277.10M | 269.70M | 278.20M | 271.90M | 268.70M | 268.30M | 244.60M |
| Goodwill | 398.20M | 399.10M | 399.00M | 399.80M | 397.60M | 388.40M | 382.50M | 392.30M | 388.20M | 397.50M | 399.30M | 357.90M |
| Intangible Assets | 65.30M | 68.90M | 67.70M | 63.30M | 78.30M | 72.80M | 65.40M | 63.60M | 61.40M | 57.70M | 57.30M | 47.80M |
| Total Assets | 1.85B | 1.82B | 1.83B | 1.80B | 1.81B | 1.77B | 1.73B | 1.80B | 1.70B | 1.73B | 1.71B | 1.62B |
| Accounts Payable | 169.40M | 138.50M | 174.70M | 162.20M | 149.40M | 169.50M | 163.80M | 169.00M | 147.70M | 166.40M | 163.60M | 146.10M |
| Total Current Liabilities | 368.10M | 334.80M | 360.10M | 356.10M | 337.40M | 357.60M | 371.40M | 373.10M | 332.80M | 364.90M | 371.50M | 344.20M |
| Total Liabilities | 495.20M | 467.60M | 499.50M | 496.50M | 504.60M | 508.90M | 518.60M | 550.10M | 504.40M | 546.60M | 557.80M | 490.50M |
| Shareholders' Equity | 1.34B | 1.34B | 1.33B | 1.30B | 1.30B | 1.26B | 1.21B | 1.24B | 1.19B | 1.18B | 1.15B | 1.13B |
| Retained Earnings | 1.14B | 1.13B | 1.10B | 1.07B | 1.06B | 1.06B | 1.02B | 1.12B | 1.08B | 1.07B | 1.03B | 1.01B |
| Net Cash (Debt) | 250.20M | 289.10M | 292.50M | 270.80M | 266.60M | 299.80M | 289.20M | 303.80M | 240.20M | 270.10M | 203.70M | 207.20M |
This table shows 12 quarterly periods of Innospec's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow IOSP's reporting calendar. What is a balance sheet?